Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.14B |
| 2 |
Microsoft
MSFT
|
+$2.98B |
| 3 |
UnitedHealth
UNH
|
+$2.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.59B |
| 5 |
CRH
CRH
|
+$2.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.01B |
| 2 |
Flutter Entertainment
FLUT
|
+$1.59B |
| 3 |
Welltower
WELL
|
+$841M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$798M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$752M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.01% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Gaia
GAIA
$46.8M
| $2.47M | ﹤0.01% |
640,321
+293
| +0% | +$1.37K |
|
3427
Lee Enterprises
LEE
$172M
| $2.46M | ﹤0.01% |
237,265
| – | – |
|
|
NPB
3428
Northpointe Bancshares
NPB
$605M
| $2.46M | ﹤0.01% |
+170,452
| New | +$2.44M |
|
3429
Adicet Bio
ACET
$85.2M
| $2.42M | ﹤0.01% |
200,368
| – | – |
|
3430
Canterbury Park Holding Corp
CPHC
$78.8M
| $2.41M | ﹤0.01% |
131,847
+12
| +0% | +$243 |
|
3431
First Seacoast Bancorp
FSEA
$79.6M
| $2.4M | ﹤0.01% |
206,202
| – | – |
|
3432
PSQ Holdings
PSQH
$13.9M
| $2.4M | ﹤0.01% |
69,885
+9,026
| +15% | +$459K |
|
3433
iShares Russell 2000 Growth ETF
IWO
$14.3B
| $2.4M | ﹤0.01% |
9,376
+7
| +0.1% | +$1.98K |
|
3434
Biodesix
BDSX
$220M
| $2.39M | ﹤0.01% |
191,185
| – | – |
|
3435
Pyxis Oncology
PYXS
$168M
| $2.39M | ﹤0.01% |
2,436,728
-4,425
| -0.2% | -$5.9K |
|
3436
Nautilus Biotechnolgy
NAUT
$124M
| $2.39M | ﹤0.01% |
2,772,708
-5,741
| -0.2% | -$8.53K |
|
|
VCSA
3437
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $2.38M | ﹤0.01% |
443,077
+81,056
| +22% | +$419K |
|
3438
Quest Resource Holding
QRHC
$26.8M
| $2.38M | ﹤0.01% |
916,673
-13,050
| -1% | -$61.8K |
|
3439
Rhinebeck Bancorp
RBKB
$188M
| $2.38M | ﹤0.01% |
242,118
| – | – |
|
3440
VirTra
VTSI
$34.9M
| $2.38M | ﹤0.01% |
584,626
-8,477
| -1% | -$50.7K |
|
3441
Hyperfine
HYPR
$92.9M
| $2.38M | ﹤0.01% |
3,321,836
+144,727
| +5% | +$149K |
|
3442
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
| $2.37M | ﹤0.01% |
14,778
+2,010
| +16% | +$329K |
|
3443
PMV Pharmaceuticals
PMVP
$59.2M
| $2.37M | ﹤0.01% |
2,175,061
+31,959
| +1% | +$43.4K |
|
3444
Wrap Technologies
WRAP
$103M
| $2.35M | ﹤0.01% |
1,375,926
+136,076
| +11% | +$282K |
|
3445
TELA Bio
TELA
$32.7M
| $2.35M | ﹤0.01% |
1,928,173
+52,594
| +3% | +$129K |
|
3446
Rapid Micro Biosystems
RPID
$106M
| $2.35M | ﹤0.01% |
890,278
+169,145
| +23% | +$386K |
|
|
VBFC
3447
DELISTED
Village Bank and Trust Financial Corp.
VBFC
| $2.34M | ﹤0.01% |
29,124
+3,700
| +15% | +$292K |
|
3448
Unusual Machines
UMAC
$1.01B
| $2.33M | ﹤0.01% |
364,226
+166,766
| +84% | +$1.69M |
|
|
VOXX
3449
DELISTED
VOXX International Corporation Class A
VOXX
| $2.33M | ﹤0.01% |
310,242
+63,599
| +26% | +$472K |
|
3450
Tenaya Therapeutics
TNYA
$161M
| $2.33M | ﹤0.01% |
4,082,032
+809,988
| +25% | +$799K |
|
Similar funds
Vanguard Group's Q1 2025 Portfolio in Review
As of Q1 2025, Vanguard Group held 4,371 positions worth $5.53T, down 3.7% from $5.74T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.9%. Vanguard Group opened 78 new positions and exited 91, leaving the 4,371-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2025 buy was Sandisk: 13,684,572 shares worth $652M.
- Vanguard Group added most to Eli Lilly in Q1 2025, an estimated $4.14B increase.
- Vanguard Group's biggest Q1 2025 reduction was Palantir, cutting an estimated $2.01B.
- Vanguard Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $798M.
- Vanguard Group's ten largest holdings make up 26% of its $5.53T portfolio in Q1 2025.
- Vanguard Group opened 78 new positions and closed 91 in Q1 2025.
- Vanguard Group's portfolio value fell 3.7% quarter-over-quarter to $5.53T.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.